ZFP36L2 and COVID-19: In their study, IFI44L in B cells, S100A8 in monocytes, and NCR2 in natural killer cells were identified as crucial markers that are involved in the innate immune response of COVID-19, while it was also demonstrated that ZFP36L2 in CD4+ T cells can regulate the inflammatory process of COVID-19 [4].